October 20, 2020 18:44 | About us
Language: Tiếng Việt | ພາ​ສາ​ລາວ | ខ្មែរ | русский | 中文

Japanese Aska enterprise acquires 24.9 percent stake in Vietnam drug firm

07:49 | 25/08/2020

The Tokyo-based company said in a recent statement that Hataphar, formally Ha Tay Pharmaceutical Jsc. was the second largest drug in company in Vietnam last year.

six vietnamese firms belonged to forbes asias best under a billion list Six Vietnamese firms belonged to Forbes Asia's Best Under A Billion list
huawei faces mortal threat china stands firmly against us suppression Huawei faces mortal threat, China stands firmly against US suppression
covid 19 in vietnam total 989 positive cases after six more confirmed over 87000 quarantined COVID-19 in Vietnam: Total 989 positive cases after six more confirmed; over 87,000 quarantined
japanese aska enterprise acquires 249 percent stake in vietnam drug firm
(Photo: Forbes Vietnam)

The Tokyo-based company said that Hataphar, formally Ha Tay Pharmaceutical Jsc, was the second largest drug company in Vietnam last year and the deal would help it get a foothold in Southeast Asia as part of its international expansion, according to Vietnam Insider.

Le Xuan Thang, CEO of Hataphar, said that the company would issue an additional 5.28 million shares equivalent to a 20 percent stake at a price of VND370 billion ($16 million). The Japanese company would purchase the remaining 4.9 percent from existing shareholders.

Collaborating through this transaction will create a synergy between Hataphar's commercial structure and our pharmaceutical manufacturing and development capabilities and technology, said Aska.

japanese aska enterprise acquires 249 percent stake in vietnam drug firm
(Photo: Vietnam Investment Review)

Aska is a 100-year-old Japanese pharmaceutical company, born in 1920, specializing in products for internal medicine, obstetrics, gynecology and urology. From April 2020, the company established an international sales division to begin promoting growth and development through operations in overseas markets.

The Japanese pharmaceutical company said that the purpose of the transaction is to establish business locations in Southeast Asia and build a platform to expand operations in the international market, reported by Monetary Security.

Hataphar plans to use the proceeds to build a VND1.35 trillion ($58.2 million) plant in Hoa Lac Hi-Tech Park in Hanoi. Construction is set to begin in the last quarter of next year.

It reported revenues of VND915 billion in the first half, up 1 percent year-on-year, while post-tax profits grew by 6 percent to VND52.5 billion.

vietnamese japanese enterprises to gather at good goods japan exhibition Vietnamese, Japanese enterprises to gather at “Good Goods Japan” exhibition

"GOOD GOODS Japan" exhibition will take place in Hanoi from August 24 to October 30, bringing together consumer goods enterprises from Japan and Vietnam.

thousands of japanese enterprises consider expanding production in vietnam Thousands of Japanese enterprises consider expanding production in Vietnam

1,400 - more than 40% of the 3,500 Japanese businesses surveyed by JETRO - are considering expanding operations in Vietnam over the next three years.

over 20000 export enterprises are ready for evfta opportunities Over 20,000 export enterprises are ready for EVFTA opportunities

More than 20,000 export enteprises in Ho Chi Minh City are fully prepared for the opportunities from EVFTA. They are ready to enjoy quick access ...

Candy Lee